All studies
Ongoing, recruitingHuman Pharmacology (Phase I)- First administration to humansInterventional
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
At a glance
Status
Ongoing, recruiting
Phase
Human Pharmacology (Phase I)- First administration to humans
Sponsor
Seagen Inc.
Enrolment target
45
Start
08 Aug 2023
Who may be eligible?
Age 18 Years to any · Sex: All
Locations (3)
- —France
- —Italy
- —Germany
How to find out more
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.